LBA16 Primary analysis of efficacy and safety in the CUPISCO trial: A randomised, global study of targeted therapy or cancer immunotherapy guided by comprehensive genomic profiling (CGP) vs platinum-based chemotherapy (CTX) in newly diagnosed, unfavourable cancer of unknown primary (CUP)
| Autor: | Mileshkin, L., Bochtler, T., Pauli, C., Durán-Pacheco, G., Arslan, C., Bigot, F., Chalabi, N., Cook, N., Italiano, A., Losa, F., Menezes, J., Michaud, C., Ozguroglu, M., Pazo Cid, R.A., Ross, J.S., Shiu, K-K., Stahl, M., Thomas, M., Moch, H., Krämer, A. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S1254-S1255 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|